BCM
TLSI icon

Basso Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Basso Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-249,569
Closed -$2.48M – 99
2022
Q3 		$2.48M Sell
249,569
-452
-0.2% -$4.47K 0.6% 62
2022
Q2 		$2.46M Hold
250,021
– – 0.26% 147
2022
Q1 		$2.45M Buy
+250,021
New +$2.47M 0.24% 160
2021
Q4 		– Sell
-58,718
Closed -$583K – 568
2021
Q3 		$583K Buy
58,718
+22,375
+62% +$219K 0.07% 263
2021
Q2 		$353K Buy
+36,343
New +$356K 0.05% 298

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Basso Capital Management's TLSI Position: Q4 2022 in Review

Basso Capital Management sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 249,569 shares — an estimated $2.48M sold.

Basso Capital Management first reported a position in TLSI in Q2 2021 and held it in 5 quarters. The position peaked at $2.48M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Basso Capital Management reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Basso Capital Management sold 249,569 TriSalus Life Sciences shares in Q4 2022, an estimated $2.48M.
  • Basso Capital Management first reported a position in TriSalus Life Sciences in Q2 2021 and held it in 5 quarters.
  • Basso Capital Management's TriSalus Life Sciences position peaked at $2.48M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.